Back to Search
Start Over
Guardant companion diagnostic gets FDA nod as 1st liquid biopsy with NGS
- Source :
- Legal Monitor Worldwide. August 11, 2020
- Publication Year :
- 2020
-
Abstract
- FDA Friday approved Guardant Health's liquid biopsy diagnostic that uses next-generation sequencing (NGS) to identify patients with mutations of the epidermal growth factor receptor (EGFR) gene in metastatic non-small cell [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Legal Monitor Worldwide
- Publication Type :
- News
- Accession number :
- edsgcl.632154461